The Role of Myocardial Perfusion Imaging in the Prediction of Major Adverse Cardiovascular Events at 1 Year Follow-Up: A Single Center's Experience.

SPECT study coronary artery disease major adverse cardiovascular events mortality myocardial perfusion imaging

Journal

Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269

Informations de publication

Date de publication:
22 May 2023
Historique:
received: 01 04 2023
revised: 14 05 2023
accepted: 16 05 2023
medline: 27 5 2023
pubmed: 27 5 2023
entrez: 27 5 2023
Statut: epublish

Résumé

Myocardial perfusion imaging via single-photon emission computed tomography (SPECT MPI) is a well-established method of diagnosing coronary artery disease (CAD). The purpose of this study was to assess the role of SPECT MPI in predicting major cardiovascular events. The study population was composed of 614 consecutive patients (mean age: 67 years, 55% male) referred for SPECT MPI due to symptoms of stable CAD. The SPECT MPI was performed using a single-day protocol. We conducted a follow-up on all patients at 12 months via a telephone interview. The majority of our patients (78%) presented findings suggestive of reversible ischemia, fixed defects or both. Extensive perfusion defects were found in 18% of the population, while LV dilation was found in 7%. During the 12-month follow-up, 16 deaths, 8 non-fatal MIs and 20 non-fatal strokes were recorded. There was no significant association of SPECT findings with the combined endpoint of all-cause death, non-fatal MI and non-fatal stroke. The presence of extensive perfusion defects was an independent predictor of mortality at 12 months (HR: 2.90, 95% CI: 1.05, 8.06, In a high-risk patient population with suspected stable CAD, only large reversible perfusion defects in SPECT MPI were independently associated with mortality at 1 year. Further trials are needed to validate our findings and refine the role of SPECT MPI findings in the diagnosis and prognosis of cardiovascular patients.

Sections du résumé

BACKGROUND BACKGROUND
Myocardial perfusion imaging via single-photon emission computed tomography (SPECT MPI) is a well-established method of diagnosing coronary artery disease (CAD). The purpose of this study was to assess the role of SPECT MPI in predicting major cardiovascular events.
METHODS METHODS
The study population was composed of 614 consecutive patients (mean age: 67 years, 55% male) referred for SPECT MPI due to symptoms of stable CAD. The SPECT MPI was performed using a single-day protocol. We conducted a follow-up on all patients at 12 months via a telephone interview.
RESULTS RESULTS
The majority of our patients (78%) presented findings suggestive of reversible ischemia, fixed defects or both. Extensive perfusion defects were found in 18% of the population, while LV dilation was found in 7%. During the 12-month follow-up, 16 deaths, 8 non-fatal MIs and 20 non-fatal strokes were recorded. There was no significant association of SPECT findings with the combined endpoint of all-cause death, non-fatal MI and non-fatal stroke. The presence of extensive perfusion defects was an independent predictor of mortality at 12 months (HR: 2.90, 95% CI: 1.05, 8.06,
CONCLUSIONS CONCLUSIONS
In a high-risk patient population with suspected stable CAD, only large reversible perfusion defects in SPECT MPI were independently associated with mortality at 1 year. Further trials are needed to validate our findings and refine the role of SPECT MPI findings in the diagnosis and prognosis of cardiovascular patients.

Identifiants

pubmed: 37241041
pii: jpm13050871
doi: 10.3390/jpm13050871
pmc: PMC10223725
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Nucl Cardiol. 2018 Jun;25(3):724-737
pubmed: 28948540
J Cardiol. 2022 Jul;80(1):64-71
pubmed: 34728122
Am J Cardiol. 1994 Oct 15;74(8):769-71
pubmed: 7942546
Diagnostics (Basel). 2021 Jun 16;11(6):
pubmed: 34208558
JACC Cardiovasc Imaging. 2018 Jul;11(7):1000-1009
pubmed: 29055639
J Am Coll Cardiol. 2005 Mar 1;45(5):722-9
pubmed: 15734617
Eur Heart J. 2020 Jan 14;41(3):407-477
pubmed: 31504439
J Nucl Cardiol. 2017 Dec;24(6):2064-2128
pubmed: 28916938
Hellenic J Cardiol. 2023 May-Jun;71:8-15
pubmed: 36566838
Eur Heart J. 2013 May;34(18):1323-36
pubmed: 23420867
J Nucl Cardiol. 2012 Aug;19(4):735-42
pubmed: 22565241
Eur J Nucl Med Mol Imaging. 2015 Nov;42(12):1929-40
pubmed: 26290421
Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1813-1821
pubmed: 33219463
J Nucl Cardiol. 2022 Feb;29(1):141-154
pubmed: 33389636
JACC Cardiovasc Imaging. 2020 Mar;13(3):774-785
pubmed: 31202740
J Xray Sci Technol. 2021;29(2):347-360
pubmed: 33492269
Int J Cardiol. 2022 Jul 1;358:120-127
pubmed: 35436561
J Nucl Cardiol. 2021 Dec;28(6):3025-3037
pubmed: 33000403
Ont Health Technol Assess Ser. 2010;10(8):1-64
pubmed: 23074411
Eur J Nucl Med Mol Imaging. 2021 Oct;48(11):3512-3521
pubmed: 33884468
Eur Heart J. 2016 Nov 7;37(42):3232-3245
pubmed: 27523477
J Cardiol. 2022 Nov;80(5):475-481
pubmed: 35835641

Auteurs

Paraskevi Zotou (P)

Nuclear Medicine Department, University Hospital of Ioannina, 45500 Ioannina, Greece.

Aris Bechlioulis (A)

Second Department of Cardiology, Faculty of Medicine, School of Health Sciences, University of Ioannina and University Hospital of Ioannina, 45500 Ioannina, Greece.

Spyridon Tsiouris (S)

Nuclear Medicine Department, University Hospital of Ioannina, 45500 Ioannina, Greece.

Katerina K Naka (KK)

Second Department of Cardiology, Faculty of Medicine, School of Health Sciences, University of Ioannina and University Hospital of Ioannina, 45500 Ioannina, Greece.

Xanthi Xourgia (X)

Nuclear Medicine Department, University Hospital of Ioannina, 45500 Ioannina, Greece.

Konstantinos Pappas (K)

Second Department of Cardiology, Faculty of Medicine, School of Health Sciences, University of Ioannina and University Hospital of Ioannina, 45500 Ioannina, Greece.

Lampros Lakkas (L)

Second Department of Cardiology, Faculty of Medicine, School of Health Sciences, University of Ioannina and University Hospital of Ioannina, 45500 Ioannina, Greece.

Aidonis Rammos (A)

Second Department of Cardiology, Faculty of Medicine, School of Health Sciences, University of Ioannina and University Hospital of Ioannina, 45500 Ioannina, Greece.

John Kalef-Ezra (J)

Nuclear Medicine Department, University Hospital of Ioannina, 45500 Ioannina, Greece.

Lampros K Michalis (LK)

Second Department of Cardiology, Faculty of Medicine, School of Health Sciences, University of Ioannina and University Hospital of Ioannina, 45500 Ioannina, Greece.

Andreas Fotopoulos (A)

Nuclear Medicine Department, University Hospital of Ioannina, 45500 Ioannina, Greece.

Classifications MeSH